Unlocking the
Power of
Neuroplastogens
The next generation in neuropsychiatry:
PSIL-006
Scientific Approach
We pioneer & engineer novel therapies through next-generation precision neuroscience.
Psilera was created by chemists who chose to champion psychedelics & neuroplastogens because of their untapped potential.
Neuroplastogens & next-generation psychedelics have the ability to improve the quality of life of patients suffering from a wide range of conditions.
In-House Research Pipeline
Collaborated Programs
Collaborated with AtaiBeckley on programs covering all granted and pending patents related to DMT and other related psychedelics from the DMT (N,N-dimethyltryptamine) Patent Estate licensing agreement.
Psilera is eligible for payments related to certain future development milestones, as well as certain royalties on commercial product sales.
Publications
2026
2025
2024
